Some clinical applications of MTS-type TLD detectors

An important part of any QA programme for radiotherapy is verification, in vitro or in vivo, of calculated doses and dose distributions. We studied the clinical applicability of LiF:MG, Ti sintered TL detectors produced, as type MTS-N, by the Institute of Nuclear Physics in Kraków (INP). These are solid pellets of diam 4.5mm and 0.8mm thickness. The TL reader was a modified planchet-type 770A, also produced at the INP, with linear heating and computerised glow curve recording.For analysis of in vivo applications, we measured, in a water phantom, the dose at 14 points aroud the Standard gynaecological applicator of our SELECTRON LDR/MDR afterloading unit with Cs-137 pellets and compared the measured values with doses calculated at these points by the in-house developed SELKOM computer code used for planning gynaecological brachytherapy at the Centre of Oncology in Kraków (COK). Agreement to within 5% was stated.To demonstrate the applicability of MTS dosemeters in calibration dosimetry, we studied the accuracy, stability and reproducibility of a batch of 100 detectors over several readout cycles at doses ranging from 0.5 to 2.5 Gy. At 1 Gy, the relative standard deviation of Individual Calibration Factors (ICF) over six readout cycles did not exceed 2.5% indicating that the error of dose estimation using individual MTS detectors should not exceed 2%.In an intercomparison of Co-60 beams at the COK and at Louvain performed with MTS detectors agreement to within less than 0.5% was found with an accuracy better than 1%.This work is partly supported by KBN Polish State Committee for Scientific Research, Research Project No. 8T11E02908